沃森生物(300142.SZ):上海泽润引入战略投资者是基於系统性考虑
沃森生物(300142.SZ)回覆关注函,指此次转让既有利於上海泽润与上市公司的战略推进与长期发展,不存在损害上市公司和中小投资者利益的行为。股权转让後公司仍然锁定HPV疫苗等产品的经销权,有效保障核心权益。
公司表示,上海泽润引入战略投资者是基於系统性考虑,不存在上市公司仅因激励为由而放弃上海泽润控制权的行为。该交易有助於上海泽润获取发展所需资金及产业资源,也能够缓解公司作为单一股东持续向上海泽润投入资金的短期压力,未来沃森生物也将作为上海泽润的重要股东,与此次交易的新增股东共同推动企业的快速发展。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.